Yow‐Ming Wang - Concepedia

Author

Yow‐Ming Wang

United States Food and Drug Administration ORCID

Also Known As

Issam Zineh, Wang, Yow-Ming C., Yow-Ming C Wang, Yow-Ming C. Wang, Yow-Ming Wang, Yow‐Ming C. Wang, Yow‐Ming Wang

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Amgen (United States)Center for Drug Evaluation and Research Bristol-Myers Squibb (United States)Regeneron (United States)

About

Yow‐Ming Wang is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	509
2	Engineering	2	2	33
3	Health Sciences	1	1	33
4	Natural Sciences	1	1	21
5	Public Health	1	1	11

Yow‐Ming Wang

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo Zhili Shao, Kausik Bhattacharya, Eileen Hsich, Circulation Research	2005	122
Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin Ronald A. Peck, Jan Hewett, Matthew W. Harding, Journal of Clinical Oncology	2001	106
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62) Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti, Bioanalysis	2019	92
Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors Peiming Ma, Bingbing Yang, Yow‐Ming Wang, The Journal of Clinical Pharmacology OncologyPharmacokinetic ModelingMedicineHuman Monoclonal AntibodyColorectal Cancer	2009	84
The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor John P. Duffy, Edmund Harrington, Francesco G. Salituro, ACS Medicinal Chemistry Letters	2011	82
Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys Jim Xiao, Wojciech Krzyżański, Yow‐Ming Wang, The AAPS Journal Cynomolgus MonkeysMedicineImmunologyClinical PharmacologyPharmacotherapy	2010	79
Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects Yow‐Ming Wang, Wojciech Krzyżański, Sameer Doshi, The AAPS Journal Healthy SubjectsPharmacological StudyLongevityPharmacologySingle Dose	2010	79
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes Mikkael A. Sekeres, Hagop M. Kantarjian, Pierre Fenaux, Cancer	2010	75
A Survey of Applications of Biological Products for Drug Interference of Immunogenicity Assays Yow‐Ming Wang, Lanyan Fang, Lin Zhou, Pharmaceutical Research Drug AnalysisImmunocytochemical TechniqueImmunotoxicologyMedicineBioanalysis	2012	47
Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies Junyi Li, Jeffry Florian, Elizabeth Campbell, Clinical Pharmacology & Therapeutics	2019	44

Page 1